EDTUTC-4 New YorkLog in Sign up

ODD
ODDITY Tech Ltd. Class A
stockNASDAQ

Market OpenOct 29, 2026 12:53:08 PM EDT

20.95USD+0.383%(+0.08)260,065

Pre-marketOct 29, 2026 9:04:30 AM EDT

20.80USD-0.335%(-0.07)

18.06Bid20.98Ask2.92Spread

ODD News

Day breaks

08:00 AM EDTODDITY to Announce Third Quarter 2026 Financial Results on November 11, 2026 ·

GlobeNewswire Inc.

08:00 AM EDTPharmaTher Submits Orphan Drug and Rare Pediatric Disease Designation Applications to FDA for 3D-Printed Creatine Monohydrate in GAMT Deficiency ·

Newsfile

03:48 PM EDTAlternative Investment Managers, Allocators and Select Industry Providers Meet at Uncorrelated AltsOps 2026 in New York City on October 29 ·

NewMediaWire

10:07 PM EDTImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines at BIO-Europe 2026 ·

PR Newswire

06:00 AM EDTHanchorBio and Aston Sci Join Forces to Unlock the Potential of Next-Generation Immunotherapy Through Cancer Vaccine Combinations ·

PR Newswire

01:30 AM EDTRznomics Granted Orphan Medicinal Product Designation for RZ-001 for the Treatment of Glioma by the European Commission ·

PR Newswire

06:50 AM EDTT-MAXIMUM's B7-H3-Targeted Allogeneic CAR-T MT027 Receives FDA Clearance for Phase 2 Study in Brain Metastases from Lung and Breast Cancer ·

PR Newswire

07:30 AM EDTRactigen Therapeutics Presents Positive First-in-Human Data for RAG-18 at WMS 2026, Establishing Clinical Proof-of-Mechanism for RNA Activation in Duchenne Muscular Dystrophy ·

PR Newswire

12:21 PM EDTUTR Therapeutics Inc. Announces U.S. FDA Orphan Drug Designation and Rare Pediatric Disease Designation for UTRxMYCN M1-14 ·

PR Newswire

02:49 AM EDTLeads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition ·

GlobeNewswire Inc.

03:23 PM EDTGEOSAT DEVIENT LE PREMIER PARTENAIRE EUROPÉEN DE L'ALLIANCE POUR LES DONNÉES SUR LES ODD ·

PR Newswire

07:50 AM EDTThe Next Chapter of B7-H3: From Systemic Disease to the Brain ·

PR Newswire

06:35 AM EDTOXC-201 also granted ODD by the FDA ·

Cision

10:39 PM EDTOddity Tech (ODD) Q2 2026 Earnings Call Transcript ·

The Motley Fool

08:10 AM EDTOddity Tech (ODD) Beats Q2 Earnings and Revenue Estimates ·

Zacks Investment Research

05:40 PM EDTGuidewire Software (GWRE) Q4 Earnings and Revenues Top Estimates ·

Zacks Investment Research